The stock price of Insmed Inc (NASDAQ: INSM) has jumped by 3503564 compared to previous close of 102.68. Despite this, the company has seen a gain of 6.78% in its stock price over the last five trading days. marketbeat.com reported 2025-06-20 that Investors pay close attention to the quarterly rebalancing of the S&P 500 index for good reason. First, the stocks in the S&P 500 make up approximately 80% of the total U.S. equity market.
Is It Worth Investing in Insmed Inc (NASDAQ: INSM) Right Now?
Company’s 36-month beta value is 0.78.Analysts have differing opinions on the stock, with 14 analysts rating it as a “buy,” 6 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for INSM is 185.71M, and currently, short sellers hold a 9.40% ratio of that floaft. The average trading volume of INSM on June 24, 2025 was 3.00M shares.
INSM’s Market Performance
INSM’s stock has seen a 6.78% increase for the week, with a 59.68% rise in the past month and a 31.91% gain in the past quarter. The volatility ratio for the week is 2.31%, and the volatility levels for the past 30 days are at 5.96% for Insmed Inc The simple moving average for the last 20 days is 26.23% for INSM’s stock, with a simple moving average of 42.32% for the last 200 days.
Analysts’ Opinion of INSM
Many brokerage firms have already submitted their reports for INSM stocks, with Jefferies repeating the rating for INSM by listing it as a “Buy.” The predicted price for INSM in the upcoming period, according to Jefferies is $105 based on the research report published on May 13, 2025 of the current year 2025.
RBC Capital Mkts, on the other hand, stated in their research note that they expect to see INSM reach a price target of $100. The rating they have provided for INSM stocks is “Outperform” according to the report published on February 25th, 2025.
Truist gave a rating of “Buy” to INSM, setting the target price at $48 in the report published on April 23rd of the previous year.
INSM Trading at 40.96% from the 50-Day Moving Average
After a stumble in the market that brought INSM to its low price for the period of the last 52 weeks, the company was able to rebound, for now settling with 2.54% of gains for the given period.
Stock Fundamentals for INSM
Current profitability levels for the company are sitting at:
- -2.3 for the present operating margin
- 0.76 for the gross margin
The net margin for Insmed Inc stands at -2.66. The total capital return value is set at -0.56. Equity return is now at value -890.75, with -68.42 for asset returns.
Based on Insmed Inc (INSM), the company’s capital structure generated 0.92 points at debt to capital in total, while cash flow to debt ratio is standing at -0.67. The debt to equity ratio resting at 11.53. The interest coverage ratio of the stock is -10.72.
Currently, EBITDA for the company is -814.14 million with net debt to EBITDA at -0.8. When we switch over and look at the enterprise to sales, we see a ratio of 52.34. The receivables turnover for the company is 7.98for trailing twelve months and the total asset turnover is 0.21. The liquidity ratio also appears to be rather interesting for investors as it stands at 5.86.
Conclusion
In a nutshell, Insmed Inc (INSM) has experienced a better performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.
